News
Keysight (KEYS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Keysight (KEYS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended October 2025. This widely-known consensus outlook gives
Central Garden (CENT) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Central Garden (CENT) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Best Momentum Stock to Buy for Nov. 17th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Nov. 17th:
Roku ROKU: This company, which is the leading TV streaming platform provider in
Does LendingClub (LC) Have the Potential to Rally 26.57% as Wall Street Analysts Expect?
Shares of LendingClub (LC) have gained 12% over the past four weeks to close the last trading session at $17.24, but there could still be a solid upside left in the stock if short-term price targets
Does Trimble (TRMB) Have the Potential to Rally 26.5% as Wall Street Analysts Expect?
Trimble Navigation (TRMB) closed the last trading session at $77.56, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does NetScout (NTCT) Have the Potential to Rally 32.49% as Wall Street Analysts Expect?
NetScout Systems (NTCT) closed the last trading session at $27.42, gaining 6.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade
Day One Biopharmaceuticals, Inc. (DAWN) closed the last trading session at $8.8, gaining 22.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Predict a 27.78% Upside in Mirion Technologies (MIR): Here's What You Should Know
Shares of Mirion Technologies, Inc. (MIR) have gained 3.1% over the past four weeks to close the last trading session at $24.91, but there could still be a solid upside left in the stock if
Wall Street Analysts Predict a 30.59% Upside in nLight (LASR): Here's What You Should Know
nLight (LASR) closed the last trading session at $30.5, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Does James River Group (JRVR) Have the Potential to Rally 26.75% as Wall Street Analysts Expect?
Shares of James River Group (JRVR) have gained 6.5% over the past four weeks to close the last trading session at $5.57, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 32.42% Upside in McGraw Hill, Inc. (MH): Here's What You Should Know
Shares of McGraw Hill, Inc. (MH) have gained 25.8% over the past four weeks to close the last trading session at $15.73, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 32.62% Upside in Alarm.com (ALRM): Here's What You Should Know
Alarm.com Holdings (ALRM) closed the last trading session at $50.3, gaining 1.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe Futu Holdings (FUTU) Could Rally 26.89%: Here's is How to Trade
Shares of Futu Holdings Limited Sponsored ADR (FUTU) have gained 1.4% over the past four weeks to close the last trading session at $165.77, but there could still be a solid upside left in the stock
Wall Street Analysts Believe Amazon (AMZN) Could Rally 25.44%: Here's is How to Trade
Shares of Amazon (AMZN) have gained 10.2% over the past four weeks to close the last trading session at $234.69, but there could still be a solid upside left in the stock if short-term price targets
Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect?
Enliven Therapeutics, Inc. (ELVN) closed the last trading session at $22.07, gaining 3.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, MiMedx Group, Inc (MDXG) is looking like an interesting pick, as it just reached a key level of support. MDXG's 50-day simple moving average crossed above its 200-day
OppFi's Adjusted EPS Guidance for 2025 Raised Again: Can it Deliver?
OppFi OPFI lifted its adjusted earnings per share (EPS) for 2025 on the back of strong financial and operational performance. During the recently reported quarter, OPFI registered an adjusted EPS of
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Why Universal Health Services (UHS) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Cenovus Energy (CVE) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
GSK (GSK) is a Top-Ranked Momentum Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service


